Tag: ESG
-
ESG in the Biopharma Industry: Do Well By Doing Good
The biopharma industry suffers from an image problem. Exorbitant drug prices, out-of-control healthcare costs, and the opioid crisis paint the industry as greedy and valuing profit over patients. Even the rapid development of effective vaccines against COVID-19 only provided a short-lived boost. One way biopharma companies are working to improve public perception of the industry…